GSK goes it alone for Adoair in Japan
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline and Mitsubishi Tanabe Pharma (MTP) have agreed to end a Japanese tie-up for the co-promotion of Adoair (salmeterol xinafoate plus fluticasone propionate) at the end of this month.